RVTY

#871
Revvity, Inc.
93.8800 USD
+2.09%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
93.8800
93.9400
Rango anual
83.4800
118.2600
Cambio diario
+2.09%
Variación mensual
+8.57%
Variación en los últimos 6 meses
-1.03%
Cambio anual
-1.03%
Cierres anteriores
91.9600
Abrir
93.9100
Bid
Ask
Mínimo
93.8800
High
93.9400
Volumen
5
Ver el calendario completo

Financials

Visión general Informes Estadísticas Dividendos
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor 202020212022202320242025 TTM

Revvity Inc

Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines. In 2022, a split of PerkinElmer resulted in one part, comprising its applied, food and enterprise services businesses, being sold to the private equity firm New Mountain Capital for $2.45 billion and thus no longer being public but keeping the PerkinElmer name. The other part, comprising the life sciences and diagnostics businesses, remained public but required a new name, which in 2023 was announced as Revvity, Inc. From the perspective of Revvity, the goal of creating a separate company was that its businesses might show greater profit margins and more in the way of growth potential. An associated goal was to have more financial flexibility moving forward. On May 16, 2023, the PerkinElmer stock symbol PKI was replaced by the new symbol RVTY.

Noticias